Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930046 · ClinicalTrials.gov registry record · NA
The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine
A NA study, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00930046 is a NA study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 15 participants.
The verdict
NCT00930046, a NA study, was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The investigators propose a prospective blinded randomized control trial (RCT) to assess the efficacy and safety of a simple method of continuous infusion of a local anesthetic, ropivacaine, via a surgical wound to control pain after ureteropelvic junction (UPJ) stenosis correction in children during the first 48 hrs after surgery. The investigators hypothesize that this technique will provide greater pain relief post-operatively and reduce the need for systemic opioid use along with a reduction in associated side effects of such analgesics.
Interventions
- DEVICE Ropivacaine wound catheter
- DEVICE Saline wound catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-04-24 |
| Est. Completion | 2011-09-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00930046
The ClinicalTrials.gov registry entry for NCT00930046 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropivacaine wound catheter is the first listed.
NCT00930046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00930046 about?
NCT00930046 is a clinical study titled "The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine". The investigators propose a prospective blinded randomized control trial (RCT) to assess the efficacy and safety of a simple method of continuous infusion of a local anesthetic, ropivacaine, via a surgical wound to control pain after ureteropelvic junction (UPJ) stenosis correction in children durin...
What is the current status of trial NCT00930046?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2009-04-24. Estimated completion is 2011-09-06.
What interventions are being tested in trial NCT00930046?
The interventions under investigation include: Ropivacaine wound catheter (DEVICE), Saline wound catheter (DEVICE).
Who is sponsoring clinical trial NCT00930046?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.